FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005118521> ?p ?o ?g. }

• W3005118521 endingPage "378" @default.
• W3005118521 startingPage "372" @default.
• W3005118521 abstract "Objectives The purpose of this study was to evaluate both the outcomes and toxicity of second-line actinomycin D (ActD) chemotherapy in methotrexate (MTX) - resistant low-risk postmolar gestational trophoblastic neoplasia (GTN) with 5-day ActD versus pulsed ActD. Methods This retrospective cohort study included patients with MTX-resistant low-risk postmolar GTN from 1974 to 2016. Second-line chemotherapy consisted of 5-day ActD (10–12 μg/kg per day for 5 days every 14 days) or biweekly ActD (1.25 mg/m2 every 2 weeks). Data on patient characteristics, disease presentation, treatment outcome, and toxicity were collected. Results Sixty-eight MTX-resistant patients receiving ActD as second-line chemotherapy were identified (5-day ActD, 53 patients; pulsed ActD, 15 patients). No significant differences were observed in patient/disease characteristics and sustained remission (overall rate 72%) between second-line ActD regimens. Time to hCG remission was significantly faster (median 21 vs 47 days, p = .04) and required fewer treatment cycles (median 1 vs 2, p < .001) with 5-day ActD. Thrombocytopenia was only observed with 5-day ActD (64.6 vs 0%, p < .001). The frequency (60.4 vs 16.7%, p = .009) and severity (grade 3: 37.9 vs 0%, p = .045) of oral mucositis was significantly higher with 5-day ActD. Grade 2 alopecia was significantly more frequent (70.6 vs 16.7%, p = .02) with 5-day ActD. Conclusions While 5-day ActD and pulsed ActD achieve comparable remission rates, due to its reduced toxicity, ease of administration, and patient convenience, pulsed ActD should be the treatment of choice for MTX-resistant postmolar low-risk GTN." @default.
• W3005118521 created "2020-02-14" @default.
• W3005118521 creator A5002111671 @default.
• W3005118521 creator A5007257045 @default.
• W3005118521 creator A5039044433 @default.
• W3005118521 creator A5059228694 @default.
• W3005118521 creator A5069394816 @default.
• W3005118521 creator A5086662756 @default.
• W3005118521 creator A5089158382 @default.
• W3005118521 date "2020-05-01" @default.
• W3005118521 modified "2023-10-17" @default.
• W3005118521 title "Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia" @default.
• W3005118521 cites W1546839557 @default.
• W3005118521 cites W1976871304 @default.
• W3005118521 cites W1981256649 @default.
• W3005118521 cites W1983758373 @default.
• W3005118521 cites W198455896 @default.
• W3005118521 cites W1993929333 @default.
• W3005118521 cites W2010443570 @default.
• W3005118521 cites W2021198554 @default.
• W3005118521 cites W2023952758 @default.
• W3005118521 cites W2027168297 @default.
• W3005118521 cites W2028063483 @default.
• W3005118521 cites W2035110215 @default.
• W3005118521 cites W2042920161 @default.
• W3005118521 cites W2051629412 @default.
• W3005118521 cites W2056168879 @default.
• W3005118521 cites W2058017479 @default.
• W3005118521 cites W2075959698 @default.
• W3005118521 cites W2079569621 @default.
• W3005118521 cites W2160168356 @default.
• W3005118521 cites W2168189118 @default.
• W3005118521 cites W2169960000 @default.
• W3005118521 cites W2534785053 @default.
• W3005118521 cites W2742426371 @default.
• W3005118521 cites W2767127479 @default.
• W3005118521 cites W2795947856 @default.
• W3005118521 cites W2889443765 @default.
• W3005118521 cites W2922163800 @default.
• W3005118521 cites W2937867957 @default.
• W3005118521 cites W2986605649 @default.
• W3005118521 cites W3190697283 @default.
• W3005118521 cites W4206066015 @default.
• W3005118521 cites W4254790161 @default.
• W3005118521 doi "https://doi.org/10.1016/j.ygyno.2020.02.001" @default.
• W3005118521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32037196" @default.
• W3005118521 hasPublicationYear "2020" @default.
• W3005118521 type Work @default.
• W3005118521 sameAs 3005118521 @default.
• W3005118521 citedByCount "15" @default.
• W3005118521 countsByYear W30051185212020 @default.
• W3005118521 countsByYear W30051185212021 @default.
• W3005118521 countsByYear W30051185212022 @default.
• W3005118521 countsByYear W30051185212023 @default.
• W3005118521 crossrefType "journal-article" @default.
• W3005118521 hasAuthorship W3005118521A5002111671 @default.
• W3005118521 hasAuthorship W3005118521A5007257045 @default.
• W3005118521 hasAuthorship W3005118521A5039044433 @default.
• W3005118521 hasAuthorship W3005118521A5059228694 @default.
• W3005118521 hasAuthorship W3005118521A5069394816 @default.
• W3005118521 hasAuthorship W3005118521A5086662756 @default.
• W3005118521 hasAuthorship W3005118521A5089158382 @default.
• W3005118521 hasConcept C126322002 @default.
• W3005118521 hasConcept C141071460 @default.
• W3005118521 hasConcept C2776694085 @default.
• W3005118521 hasConcept C2778496288 @default.
• W3005118521 hasConcept C2781059491 @default.
• W3005118521 hasConcept C2909593222 @default.
• W3005118521 hasConcept C29456083 @default.
• W3005118521 hasConcept C29730261 @default.
• W3005118521 hasConcept C71924100 @default.
• W3005118521 hasConcept C90924648 @default.
• W3005118521 hasConceptScore W3005118521C126322002 @default.
• W3005118521 hasConceptScore W3005118521C141071460 @default.
• W3005118521 hasConceptScore W3005118521C2776694085 @default.
• W3005118521 hasConceptScore W3005118521C2778496288 @default.
• W3005118521 hasConceptScore W3005118521C2781059491 @default.
• W3005118521 hasConceptScore W3005118521C2909593222 @default.
• W3005118521 hasConceptScore W3005118521C29456083 @default.
• W3005118521 hasConceptScore W3005118521C29730261 @default.
• W3005118521 hasConceptScore W3005118521C71924100 @default.
• W3005118521 hasConceptScore W3005118521C90924648 @default.
• W3005118521 hasFunder F4320321091 @default.
• W3005118521 hasIssue "2" @default.
• W3005118521 hasLocation W30051185211 @default.
• W3005118521 hasLocation W30051185212 @default.
• W3005118521 hasOpenAccess W3005118521 @default.
• W3005118521 hasPrimaryLocation W30051185211 @default.
• W3005118521 hasRelatedWork W1726780236 @default.
• W3005118521 hasRelatedWork W1979235320 @default.
• W3005118521 hasRelatedWork W1981575876 @default.
• W3005118521 hasRelatedWork W2032390249 @default.
• W3005118521 hasRelatedWork W2035770108 @default.
• W3005118521 hasRelatedWork W2782070887 @default.
• W3005118521 hasRelatedWork W2997164716 @default.
• W3005118521 hasRelatedWork W3025392928 @default.
• W3005118521 hasRelatedWork W3208859812 @default.
• W3005118521 hasRelatedWork W2185633120 @default.

• next